European Market Research

 
News Articles for European Market Research top ^
2015/2/16
-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) --
Sign-up for Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European markets investment picks
2014/12/9
RHB-102, newly branded as BEKINDA ™ , is a proprietary once-daily oral pill formulation of the antiemetic drug ondansetron The European marketing authorization application (MAA) seeks approval of BEKINDA ™ for cancer patients suffering from chemotherapy and radiotherapy-induced nausea and vomiting BEKINDA ™ is also being developed for acute gastroenteritis and gastritis, with a Phase III study ongoing in the U.S. and top-line data expected during H2/2015 TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma Submits BEKINDA(TM) (RHB-102) European Marketing Authorization Application for Oncology Support investment picks
2015/2/23
By Josie Cox Relief stemming from a last minute agreement struck Friday between Greece and its international creditors to extend a bailout program, continued to reverberate through European markets Monday, buoying equities and bonds.
Sign-up for European Markets Buoyed by Greek Agreement -- 3rd Update investment picks
2015/2/23
By Josie Cox Relief stemming from a last minute agreement struck Friday between Greece and its international creditors to extend a bailout program continued to reverberate through European markets Monday, buoying equities and bonds.
Sign-up for European Markets Rise After Greek Bailout Extension investment picks
2015/2/23
By Josie Cox Relief stemming from a last minute agreement struck Friday between Greece and its international creditors to extend a bailout program, continued to reverberate through European markets Monday, buoying equities and bonds.
Sign-up for European Markets Buoyed by Greek Agreement -- 2nd Update investment picks
2015/2/9
By Tommy Stubbington Greek markets tumbled on Monday after Prime Minister Alexis Tsipras stuck to his commitment that he would refuse to accept an extension of Greece's international bailout, heightening fears that the country could default on its debt, or exit the eurozone.
Sign-up for Greece Casts Shadow Over European Markets -- 4th Update investment picks
2014/12/24
By Tommy Stubbington European shares were mixed Wednesday in a holiday-shortened session ahead of the Christmas break.
Sign-up for European markets mixed ahead of Christmas break investment picks
2014/12/31
The UK MHRA has validated the European marketing application for the indications of chemotherapy and radiotherapy-induced nausea and vomiting; MHRA's feedback is expected during H2/2015 BEKINDA ™ (RHB-102) is a proprietary once-daily oral pill formulation of the antiemetic drug ondansetron, targeting a worldwide potential market with estimated annual sales of $940 million BEKINDA ™ is also being developed for acute gastroenteritis and gastritis, with an ongoing Phase III study in the U.S. and top-line data expected during H2/2015 TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma Announces Acceptance for Review of BEKINDA(TM) European Marketing Application for Oncology Support investment picks
2015/2/6
Concern over the outcome of a standoff between Greece and its creditors continued to bear down on European stock markets Friday.
Sign-up for European Markets Weighed by Greek Debt Standoff investment picks
2015/2/9
By Tommy Stubbington Greek markets tumbled Monday after Prime Minister Alexis Tsipras stuck to his commitment that he will refuse to accept an extension of Greece's international bailout, heightening investor fears that the country could default on its debt or exit the eurozone.
Sign-up for Greece Casts Shadow Over European Markets -- 3rd Update investment picks
2015/2/9
By Tommy Stubbington Greek markets tumbled Monday after Prime Minister Alexis Tsipras stuck to his commitment that he will refuse to accept an extension of Greece's international bailout, heightening investor fears that the country could default on its debt or exit the eurozone.
Sign-up for Greece Puts European Markets in a Funk -- 2nd Update investment picks
2015/1/27
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Tuesday, with shares of major industrial firms Royal Philips NV and Siemens AG among those pulling the regional market's benchmark toward its first loss in nine sessions.
Sign-up for UPDATE: Philips, Siemens shares weigh on European markets investment picks
2015/1/27
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Tuesday, with shares of major industrial firms Royal Philips NV and Siemens AG among those pulling the regional market's benchmark toward its first loss in nine sessions.
Sign-up for Philips, Siemens shares weigh on European markets investment picks
2015/2/19
By Carla Mozee, MarketWatch Greece submits loan-extension request LONDON (MarketWatch) -- European stocks dropped Thursday, with energy shares under pressure as oil prices tanked on an unexpectedly strong surge in supplies.
Sign-up for UPDATE: Energy stocks weigh on European markets, but Athens gains on Greek move investment picks
2015/2/9
By Tommy Stubbington The tense standoff between Greece and its international creditors kept European markets under pressure Monday, extending a miserable run for Greek assets and pulling stocks sharply lower across the region.
Sign-up for Greece Puts European Markets in a Funk -- Update investment picks
2015/2/9
By Tommy Stubbington The tense standoff between Greece and its international creditors kept European markets under pressure Monday, pulling stocks sharply lower.
Sign-up for Greece Puts European Markets in a Funk investment picks
2015/1/7
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks climbed Wednesday, pushing to session highs alongside a broader rally among European stocks as investors bet on further stimulus measures from the European Central Bank.
Sign-up for UPDATE: U.K. stocks pushed higher in broad European markets rally investment picks
2014/12/4
To an audience of more than 450 leaders at its European Commercial Summit, Veeva Systems announced the availability of the Veeva Network Provider Database for Europe, beginning with the top five markets.
Sign-up for Veeva Systems Announces Healthcare Professional and Healthcare Organization Data Offering for the European Market investment picks
2014/12/11
Successful Pre-Submission Meeting with European Medicines Agency Completed CRANBURY, N.J., Dec.
Sign-up for Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease investment picks
2014/12/19
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Pfizer has received EU marketing authorization for DUAVIVE® (conjugated estrogens/bazedoxifene (BZA/CE)) from the European Commission.
Sign-up for Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
European Market Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: European Investing  |  Next: European Media Enterprises